Zoetis

Does anyone have any ideas? It's not going so well. I still believe in $ZTS (+0,52 %) and $CELH not so much in $BHP (-0,11 %) but I would like to buy another stock or possibly a fund or maybe a crypto ETF?

Hello stock market friends,

I would be interested in your assessment of my Quality Growth portfolio.

I currently feel comfortable with the portfolio, even though it is very technology-focused.

My approach is to only buy absolute quality companies with positive growth prospects at fair valuations. Some companies are simply rarely available at fair valuations ($ANET
$SNPS (-1,06 %) and co.), which is why I am prepared to add such companies with strong moats to my portfolio at a premium.

I am currently considering whether $MSCI (+0,09 %) after the market punished the last quarterly figures.

I am also keeping a closer eye on $ZTS (+0,52 %) more closely due to the recent setbacks. Fundamentally, the company is still operating excellently and is starting to look more attractively valued than it did a few months ago.

What stocks do you know that could be a good addition to my portfolio?

LG

I know that advertising is not welcome here😉 but if you want you can watch my new video about $ZTS (+0,52 %) . After the recent price drop, I think they are relatively fairly and interestingly valued. What do you think of Zoetis?

https://youtu.be/1mnNUpEexew

$ZTS (+0,52 %) You are close to the 52-week low, if the support holds it may go up again. Pros are the high market value, the company makes a profit and pays dividends. Cons are the fundamental data such as P/E ratio and P/B ratio. I will take a look at $ELAN (-0,09 %) , $PETS (-3,05 %)
$PETQ in the watchlist

New addition to the depot: Zoetis

While classic pharmaceutical stocks should be well known to most, animal health is less in the spotlight.

#zoetis Zoetis is the global market leader here with medicines, vaccines, diagnostics, etc.

In recent years, a significant premium has always been paid, but this is comparatively low due to recent sales.

I therefore saw an entry opportunity and built up an initial position.

Animal health is a megatrend, as pets are becoming increasingly humanized. Pets are being treated like "real"/human family members - in the truest sense of the word.

I also see a strong positioning in the face of possibly more persistent inflation, as fewer savings are being made on pets.

At the latest at $130, I would increase significantly.

How do you rate the company? How do you see the short/medium/long-term prospects?

2nd tranche purchased yesterday

Hello everyone,

Today I would like to introduce you to my portfolio. As you probably know, it's just too much fun to expand my portfolio with new stocks. There are now a few too many, but I still can't really part with my worst-performing stocks ($NVM (-3,2 %) , $ENPH (+6,64 %) , $WAC (-0,93 %) ). I'm hoping that I'll be able to sell them in positive territory at some point, or am I on the wrong track and in your opinion should I sell at a loss and try to make up the loss with other stocks?

I have been investing since the end of 2022 and at 29 years old, I still have a long time to go. My strategy is to be as desertified as possible in sectors and to beat the market in the long term (just let me believe that it works :D), hence so many individual stocks. I want to hold these for many years (esp. $AMZN (+0,26 %) , $GOOGL (+0,94 %) , $QCOM (+2,48 %) , $MSFT (-1,05 %) , $V (-0,14 %) , $MC (-0,25 %) , $SALM (-0,11 %) ) but I'm also not too keen to pocket the profits. Are there any stocks in my portfolio that you would view critically for the next few years and would be worth considering selling? Recession and all that...

Priority is on growth, which is reasonably safe, so only a few small caps - but a few bets have to be in there :) ($AIDX (-2,2 %) , $NRX (-0,62 %) , $ITM (+2,92 %) , $F3C (-0,91 %) , $MITK (+2,05 %) ). But with rather small amounts, probably too small or what do you say?

At the same time, I would also like to claim a €900 allowance via dividends ( $BATS (-0,24 %) , $ENB (+0,76 %) , $BNPQY , $STLAM (-0,17 %) , $ENGI (+0,22 %) , $RIO (-0,93 %) ) and secure a trade or two.

Recently I have been investing 240€/m in the $XDWD (+0,24 %) and between 200 - 500€/m in individual shares (depending on what is left). Actually, I want to increase the existing shares properly now, but somehow there are always nice entry options in solid companies like $0L2T (-2,42 %) , $ZTS (+0,52 %) , $ADM (+1,28 %) , $PANW (-2,12 %) , $ENR (+2,08 %) . Help what to do? :D

And then there's also crypto $BTC (-1 %)
$NEAR (-0,15 %)
$ADA (-0,55 %)

And Japan, they're doing well too $4063 (-1,14 %) , $6501 (-2,62 %) , $8001 (-0,17 %)

Looking forward to your feedback and advice!

New addition to the portfolio

I bought a new position in my portfolio today shortly after the start of trading in the USA: Zoetis $ZTS (+0,52 %).

Zoetis is a manufacturer of medicines and vaccines for pets and livestock. The company is interesting for me for the following reasons:

• Gross margin of 70%, and rising
• ROCE of over 20%
• Market leader in almost all active segments
• High dividend growth
• diversified product portfolio
• low debt

The company operates in both the pet sector and the livestock sector. In the pet sector, there is a long-lasting trend towards regular and better medical care (regular vaccinations, cures, ...). The livestock sector is also benefiting from a sustained demand for better and more efficient medical care.

Overall, the market for veterinary medicine is expected to grow by 7-8% per year. Zoetis is already the market leader in many areas and has always managed to grow faster than the market as a whole.

Risks

This is a sector bet based on the hypothesis that there is a trend towards more and better medical care for pets and livestock. This may of course turn out to be wrong, especially in times of recession, the cost of medical care for pets may not rise (or even fall) as much as hoped.

Another risk is the current valuation. Zoetis is currently valued at a free cash flow yield of around 2.5%. A lot of growth is already priced in.

Summary

The risk/reward is attractive for me and I have opened an initial position. I will give the share time to assess the direction in which the company is developing. The price is certainly not a bargain at the moment, but for me it is still a price level at which I can open an initial position.